[Federal Register: October 7, 2003 (Volume 68, Number 194)]
[Notices]               
[Page 57929-57930]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07oc03-90]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 16, 2003, and published in the Federal Register 
on June 11, 2003, (68 FR 35006), Noramco, Inc. (formerly Noramco of 
Delaware, Inc.), 500 Swedes Landing Road, Wilmington, Delaware 19801, 
made application by renewal and on December 4 and 26, 2002, by letters 
to the Drug Enforcement Administration to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine-N-Oxide (9053)......................  I
Morphine-N-Oxide (9307).....................  I
Codeine (9050)..............................  II
Oxycodone (9143)............................  II
Hydrocodone (9193)..........................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Oxymorphone (9652)..........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk products.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Noramco, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Noramco, Inc. to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy

[[Page 57930]]

Assistant Administrator, Office of Diversion control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
is granted.

    Dated: September 17, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-25409 Filed 10-6-03; 8:45 am]

BILLING CODE 4410-09-M